News

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
Popular GLP-1 weight loss drugs like Ozempic and Zepbound may help lower a woman’s risk for 14 types of cancer, a new study ...
The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.
Terrance Trice has been charged with criminal homicide in the stabbing.
Primary care providers can use a new clinical advisory guideline to nutritionally support patients who are using GLP-1 ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Novo Nordisk (NYSE: NVO) and Cava Group (NYSE: CAVA) are excellent choices. Novo Nordisk's shares have significantly lagged ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...
Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.
Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...